in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance..
the financial times and its journalism are subject to a self-regulation regime under the ft editorial code of practice:.media won�t investigate medically-caused death numbers.we have sent you a verification email. to verify, just follow the link in the message.